Goodpasture Syndrome Anti Glomerular Basement Membrane Antibody Disease With Pulmonary Involvement

Slide 1 · Goodpasture syndrome

Anti–glomerular basement membrane antibody disease

with pulmonary involvement

Glomerular injury

Alveolar hemorrhage

Shared anti-GBM autoantibodies

Schematic

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Molecular basis

Anti-GBM antibody specificity

Pathogenesis

Why lung and kidney are injured

Morphology

Crescents and pulmonary hemorrhage

Clinicopathologic reasoning

Diagnosis, differential and treatment rationale

Slide 3 · Goodpasture syndrome: The defining lesion

KIDNEY

Glomerular basement membrane

LUNG

Alveolar basement membrane

Shared α3(IV) target

Schematic — same circulating antibodies can affect both organs

Slide 4 · Terminology depends on pulmonary involvement

Renal-limited anti-GBM disease

Goodpasture syndrome

Anti-GBM antibodies

Renal injury

No pulmonary hemorrhage

Anti-GBM antibodies

Renal injury

Pulmonary hemorrhage

Slide 5 · Where it sits among pulmonary hemorrhage syndromes

Syndrome

Underlying pattern

Goodpasture

Anti-basement-membrane antibodies

Idiopathic pulmonary hemosiderosis

Unknown cause; anti-GBM antibodies absent

Vasculitis-associated hemorrhage

Inflammatory small-vessel disease

Diffuse pulmonary hemorrhage can reflect several mechanisms • Robbins groups Goodpasture disease, idiopathic hemosiderosis, and vasculitis-associated bleeding

Slide 6 · How frequently is the lung involved?

40%–60%

Pulmonary hemorrhage among patients with anti-GBM antibody disease

Pulmonary hemorrhage in 40%–60% of patients with anti-GBM antibody disease

The remainder are categorized as renal-limited disease

Pulmonary disease is therefore defining for Goodpasture syndrome, not universal for anti-GBM disease

Slide 7 · Epidemiologic profile

The disease is uncommon and may occur at any age

Most cases occur in teenagers and people in their twenties

A male preponderance is described, unlike many autoimmune diseases

Most patients described are active smokers

Slide 8 · The central pulmonary–renal question

KIDNEY

Glomerular basement membrane

LUNG

Alveolar basement membrane

Shared α3(IV) target

Schematic — same circulating antibodies can affect both organs

Slide 9 · Basement membranes: Two vulnerable interfaces

Glomerular filtration barrier

Alveolar air–blood barrier

Shared collagen IV antigen at the basement-membrane layer

Slide 10 · The autoantigen is a defined collagen IV domain

Schematic

NC1

Region

Anti-GBM

Autoantibody

Simplified type IV collagen α3 chain antigen concept — not a molecular structure rendering

Molecular target: Noncollagenous region of collagen type IV α3 chain

Also present in glomerular and alveolar basement membranes

The recognition site is not a nonspecific marker of epithelial injury

Slide 11 · Circulating antibodies initiate tissue injury

Autoantibody

Basement-membrane binding

Inflammatory injury

Pulmonary + renal lesions

Autoantibodies bind basement-membrane epitopes in target organs

This initiates inflammation and basement-membrane destruction

Renal glomeruli and pulmonary alveoli develop different clinical consequences

Slide 12 · Renal localization produces glomerulonephritis

Schematic

Bowman space

Glomerular capillary loops

The glomerular basement membrane becomes a site of immune attack

Inflammatory damage disrupts capillary-wall integrity

Severe disease progresses to necrosis and extracapillary crescent formation

Slide 13 · Pulmonary localization produces alveolar hemorrhage

Schematic

Alveolar airspaces

Basement-membrane injury involves alveolar septal walls

Focal septal necrosis permits blood to enter airspaces

The pathologic lesion is necrotizing hemorrhagic interstitial pneumonitis

Slide 14 · One antibody specificity, two injury patterns

Kidney

Lung

Glomerular BM injury

Crescentic nephritis

Progressive renal failure

Alveolar septal injury

Intraalveolar blood

Hemoptysis / consolidations

Slide 15 · The initiating trigger remains uncertain

Unknown

Initiating trigger for autoantibody formation

The initiating event that produces anti-GBM autoantibodies is unknown

Robbins mentions implicated exposures, not established universal causes

Do not treat association as proof of causation

Slide 16 · Genetic susceptibility: HLA association

Associations include HLA-DRB1*1501 and HLA-DRB1*1502

These associations are compatible with a predisposition to autoimmunity

HLA association is not equivalent to a diagnostic genotype

Slide 17 · B cells generate the pathogenic antibodies

Autoreactive B cells

Anti-GBM antibodies

Target binding

Inflammatory damage

Autoreactive B cells are implicated in antibody production

The circulating antibodies directly bind the target basement membranes

Removal of circulating antibodies is consequently a therapeutic target

Slide 18 · Possible T-cell involvement is qualified

Experimental data suggest T cells can enhance B-cell function

T cells may also participate directly in glomerular damage and crescents

This as supporting evidence, not complete mechanistic resolution

Slide 19 · Reported potential exposures are not definitive causes

Reported association

Interpretive status

Viruses

Implicated in some patients

Hydrocarbon solvents

Implicated in some patients

Drugs / cancers

Implicated in some patients

Specific universal trigger

Not established

The textbook implicates viruses, hydrocarbon solvents, certain drugs, and cancers in some patients • Exposure histories may provide context but do not establish causality

Slide 20 · Glomerular capillary damage creates urinary-space leakage

Schematic

Bowman space

Glomerular capillary loops

Damaged GBM can develop ruptures in severe crescentic GN

Plasma proteins, immune mediators, and cells gain access to Bowman space

This process promotes epithelial and inflammatory-cell crescent formation

Slide 21 · The crescent is a response to severe capillary injury

Schematic

Crescent cells

Crescents form in Bowman space external to the glomerular tuft

They contain proliferating epithelial cells and inflammatory cells

Crescents compress the tuft and can obliterate urinary space

Slide 22 · A causal map from antibody to organ failure

Anti-GBM binding

Capillary-wall injury

Hemorrhage / crescents

Functional decline

Linear antibody deposition localizes the immunologic attack

Capillary-wall injury produces lung hemorrhage and glomerular disruption

Crescentic glomerulonephritis can evolve rapidly toward renal failure

Slide 23 · Kidney involvement may begin focally

Early cases can show focal proliferative glomerulonephritis

The morphologic pattern evolves as the antibody-mediated process progresses

Clinical severity cannot be deduced from the word “focal” alone

Slide 24 · Crescentic glomerulonephritis marks severe disease

Schematic

Crescent cells

Rapidly progressive GN often shows extracapillary crescents

Segmental glomerular necrosis and GBM damage may coexist

Crescents reflect structural injury rather than a specific etiology

Slide 25 · Crescent constituents have diagnostic meaning

Schematic

Bowman space

Glomerular capillary loops

Proliferating glomerular epithelial cells line portions of Bowman space

Monocytes and macrophages accumulate within crescents

Fibrin may be visible between cellular layers

Slide 26 · Why crescents reduce filtration

Capillary injury

Extracapillary crescent

Tuft compression

Renal dysfunction

Expanding extracapillary cellular tissue compresses the glomerular tuft

Disrupted glomerular capillaries lose effective filtration surface

Severe diffuse injury causes rapidly declining renal function

Slide 27 · Renal gross changes are not specific

In crescentic glomerulonephritis, kidneys may be enlarged and pale

Petechial cortical hemorrhages may be present

These findings require immunopathologic correlation for etiologic attribution

Slide 28 · Renal immunofluorescence is distinctive

Linear GBM staining

Native schematic

Continuous antibody localization along a basement-membrane surface

Schematic immunofluorescence pattern — not a patient biopsy

Slide 29 · Linear versus granular immunofluorescence

Linear

Granular

Pauci-immune

Schematic immunofluorescence pattern — not a patient biopsy

Slide 30 · Three immunopathologic categories of crescentic GN

Category

IF pattern

Illustrative mechanism

Anti-GBM (I)

Linear IgG ± C3

Basement-membrane antibodies

Immune complex (II)

Granular immune deposits

Immune-complex deposition

Pauci-immune (III)

Little / no deposits

Commonly ANCA-associated

Type I: Anti-GBM antibodies with linear immunofluorescence • Type II: Immune complexes with granular immunofluorescence

Slide 31 · Immunofluorescence identifies the disease mechanism

Pulmonary compartment

Renal compartment

Antibody mechanism & immunofluorescence

A crescent is a morphologic reaction and is not etiologically unique

Linear GBM immune deposits identify an anti-GBM mechanism

Combine light microscopy, immunofluorescence, and serology for interpretation

Slide 32 · Kidney damage can become irreversible

Active necrosis

Cellular crescents

Organization

Fibrous scarring

Crescents may organize and develop a fibrous component over time

Segmental necrotic lesions may heal with segmental sclerosis

Early intervention may allow recovery before extensive scarring

Slide 33 · Macroscopic lung pathology: Hemorrhagic consolidation

Classically the lungs are heavy

Red-brown areas of consolidation may be present

Gross discoloration corresponds to blood accumulation and breakdown

Slide 34 · Alveolar-wall necrosis is the primary lesion

Schematic

Alveolar airspaces

Histology shows focal necrosis of alveolar septal walls

Associated hemorrhage fills intraalveolar spaces

Inflammation and bleeding are linked to capillary basement-membrane injury

Slide 35 · Intraalveolar hemorrhage explains hemoptysis

Septal injury

Blood enters alveoli

Hemoptysis

Pulmonary consolidation

Blood entering airspaces may be expelled as hemoptysis

The same blood can obscure normal aeration on chest imaging

Pulmonary manifestations may precede overt renal symptoms

Slide 36 · Hemosiderin-laden macrophages document prior bleeding

Schematic

Alveolar airspaces

Alveolar macrophages phagocytose extravasated erythrocytes

Hemoglobin breakdown produces intracellular hemosiderin

Repeated or resolving hemorrhage can leave numerous pigmented macrophages

Slide 37 · Prussian-blue staining confirms the pigment

H&E examination

Prussian-blue reaction

Alveolar red cells

Pigmented macrophages

Morphologic hemorrhage

Macrophage iron positivity

Confirms hemosiderin

Not etiologically specific

Slide 38 · Late pulmonary changes may be organizing

Septal necrosis

Alveolar hemorrhage

Macrophage response

Organization / fibrosis

Fibrous thickening of interalveolar septa can develop

Type II pneumocyte hyperplasia may appear

Organization of intraalveolar blood accompanies healing or persistent damage

Slide 39 · Pulmonary immunofluorescence may be linear

Linear GBM staining

Native schematic

Continuous antibody localization along a basement-membrane surface

Schematic immunofluorescence pattern — not a patient biopsy

Slide 40 · What a pulmonary hemorrhage specimen proves

Pulmonary compartment

Renal compartment

Antibody mechanism & immunofluorescence

RBCs and hemosiderin-laden macrophages establish alveolar bleeding

They do not alone identify an anti-GBM cause

Renal immunopathology and anti-GBM serology supply mechanistic specificity

Slide 41 · Kidney and lung: Integrated morphology

Renal compartment

Pulmonary compartment

Glomerular capillary wall

Crescents / renal failure

Linear GBM deposits

Alveolar septal wall

Alveolar hemorrhage

Sometimes linear septal deposits

Slide 42 · Pulmonary pathology differential is wide

Cause group

Clue to mechanism

Anti-GBM

Linear GBM deposits / anti-GBM antibodies

Idiopathic hemosiderosis

Anti-GBM antibodies absent

Vasculitis-associated

Clinical / pathologic vasculitis features

Alveolar hemorrhage is a shared pathologic pattern • Vasculitides and idiopathic hemosiderosis also produce alveolar bleeding

Slide 43 · Clinical presentation often starts in the lung

Hemoptysis

Pulmonary consolidation

Glomerulonephritis

Progressive renal failure

Respiratory symptoms as the initial presentation in most cases

Hemoptysis is a principal symptom

Chest imaging may show focal pulmonary consolidations

Slide 44 · Pulmonary hemorrhage may be life-threatening

Recurrent hemoptysis may dominate the clinical course

Severe bleeding can compromise respiratory function

Do not dismiss ongoing alveolar hemorrhage because renal symptoms are initially subtle

Slide 45 · Nephritic urine abnormalities indicate glomerular injury

Schematic

Bowman space

Glomerular capillary loops

Hematuria and red blood cell casts characterize the renal syndrome

Proteinuria accompanies damaged glomerular filtration barriers

Correlate urine findings with evolving renal functional impairment

Slide 46 · Other renal manifestations follow capillary injury

Blood pressure may be elevated

Edema can accompany impaired renal function

Proteinuria is usually moderate but may occasionally reach nephrotic range

Slide 47 · Rapidly progressive renal dysfunction is characteristic

Hematuria

Falling filtration

Oliguria

Severe renal failure

Renal decline often evolves over weeks

Severe oliguria may develop

The syndrome can advance to severe renal failure if treatment is delayed

Slide 48 · Uremia was historically a major cause of death

Uremia as the most common cause of death

This emphasizes the clinical severity of glomerular injury

Treatment has substantially improved outcomes compared with historical prognosis

Slide 49 · Recognizing the pulmonary–renal syndrome

Pulmonary compartment

Renal compartment

Antibody mechanism & immunofluorescence

Hemoptysis plus glomerular hematuria suggests a shared systemic process

A rapidly falling renal function warrants urgent mechanistic evaluation

Goodpasture syndrome is one important cause, not the sole cause

Slide 50 · Initial diagnostic evidence must be integrated

Pulmonary compartment

Renal compartment

Antibody mechanism & immunofluorescence

Serum anti-GBM antibody measurement helps identify the cause

Urinalysis and renal-function testing define the nephritic phenotype

Biopsy and immunofluorescence establish the tissue injury pattern

Slide 51 · Serologic classification avoids single-test reasoning

Investigation

Interpretive role

Serum anti-GBM antibodies

Supports anti-GBM mechanism

ANCA

Evaluates pauci-immune vasculitis

ANA

Assesses immune-complex / autoimmune alternatives

Renal IF

Distinguishes linear / granular / pauci patterns

Anti-GBM antibodies identify an antibody-mediated possibility • ANCA and antinuclear antibody testing assist differential diagnosis

Slide 52 · Idiopathic pulmonary hemosiderosis differs mechanistically

Goodpasture syndrome

Idiopathic hemosiderosis

Anti-GBM antibodies

Renal glomerular injury

Pulmonary hemorrhage

Antibodies undetectable

Unknown mechanism

Intermittent alveolar hemorrhage

Slide 53 · Granulomatosis with polyangiitis is another comparator

Anti-GBM disease

GPA

Antibody to collagen IV α3

Linear renal IF

Pulmonary hemorrhage

Vasculitis-associated injury

Capillaritis / granulomas

May cause pulmonary hemorrhage

Slide 54 · Renal IF is a high-yield diagnostic discriminator

Linear

Granular

Pauci-immune

Schematic immunofluorescence pattern — not a patient biopsy

Slide 55 · Why plasma exchange is mechanistically rational

Circulating antibodies

Plasma exchange

Antibody removal

Less continuing injury

Plasma exchange removes circulating pathogenic anti-GBM antibodies

It may also remove other soluble mediators of injury

The objective is to reduce continuing basement-membrane attack

Slide 56 · Why immunosuppression must accompany exchange

Plasma exchange

Immunosuppression

Removes circulating antibody

Reduces immediate antibody load

Addresses existing mediator

Suppresses new production

Reduces ongoing immune attack

Addresses immune source

Slide 57 · Early treatment matters for renal recovery

Early recognition

Antibody removal

Suppress production

Preserve organ function

Early plasma exchange with steroids and cytotoxic therapy may allow renal recovery

Pulmonary hemorrhage may improve with suppression of the immune process

Advanced scarring and late presentation limit the prospect of recovery

Slide 58 · Case: Hemoptysis followed by nephritic urine

A young adult develops hemoptysis and new urinary red blood cell casts

Renal function deteriorates over the following weeks

What mechanism unifies the pulmonary and renal findings?

What mechanism or diagnosis best explains the pattern?

Slide 59 · Case interpretation: The decisive histologic pattern

Kidney biopsy shows crescents and continuous linear IgG along GBM

A crescent alone would not identify the cause

Linear immunofluorescence supports anti-GBM crescentic GN

Diagnostic distinction: Linear GBM staining identifies anti-GBM injury; Crescents indicate severity.

Slide 60 · Case: Hemorrhage with negative anti-GBM antibodies

A child has intermittent diffuse alveolar hemorrhage and anemia

Anti-basement membrane antibodies are undetectable

Why is idiopathic pulmonary hemosiderosis a competing diagnosis?

What mechanism or diagnosis best explains the pattern?

Slide 61 · Case: Crescentic GN with granular deposits

The biopsy shows crescents, but IF has granular Ig and complement deposits

Which classification does that pattern favor?

What conclusion should not be drawn from crescents alone?

What mechanism or diagnosis best explains the pattern?

Slide 62 · Three diagnostic pitfalls

Pitfall

Corrective principle

Alveolar hemorrhage = Goodpasture

Different causes share the same lung pattern

Any crescent = anti-GBM

Classify by renal IF and serology

Suspected exposure = cause

Trigger remains uncertain

Equating all alveolar hemorrhage with Goodpasture syndrome • Treating all crescentic glomerulonephritis as anti-GBM disease

Slide 63 · Concept synthesis: Evidence at three levels

MOLECULAR

Antibody to collagen IV α3 noncollagenous domain

MORPHOLOGIC

Glomerular crescents, linear GBM deposits, alveolar hemorrhage

CLINICAL

Hemoptysis plus rapidly progressive nephritic renal disease

Slide 64 · The disease in one causal sequence

Anti-GBM autoantibody

Lung + kidney binding

Hemorrhage + crescents

Therapeutic interruption

Autoantibody formation → shared basement-membrane targeting

Inflammatory capillary injury → lung hemorrhage and glomerular damage

Plasma exchange plus immunosuppression interrupts ongoing immune injury

Slide 65 · High-yield diagnostic checklist

Pulmonary evidence: Hemoptysis / infiltrates / alveolar hemorrhage

Renal evidence: Hematuria, RBC casts, renal decline

Mechanistic evidence: Anti-GBM antibodies and linear GBM immunofluorescence

Differentiate immune-complex and pauci-immune processes

Slide 66 · Suggested reading

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition.

The Lung: diffuse pulmonary hemorrhage and Goodpasture syndrome.

The Kidney: anti-GBM disease and crescentic glomerulonephritis.

Detailed source location and diagram provenance are provided in instructor notes.